Kenneth Hideo Akizuki, MD
Orthopedic Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Offices
- 5
Offices
5 locations · Golden State Orthopedics and Spine · 186 clinicians in this group
Looking this up.
Hospitals listed: Marinhealth Medical Center · Novato Community Hospital · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Akizuki’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G82335 · Current
Licensed to practise in California · since 1996 · expires 2028-06-30 · George Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Pacific Heights Surgery Center of San Francisco, L.P. dba Pacific Heights Surgery CenterAmbulatory Surgery Center · San Francisco, CA8.62% owner since 2006 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2026-05-14
- SOAR Surgery Center, LLCAmbulatory Surgery Center · Burlingame, CA11.1% owner · accredited by AAAHCAccreditation RenewedNo inspections published
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$118,490
Medicare paid this office $118,490 for 276 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 142 | $24,072 | $119 |
| Short return visit (20+ min) | 151 | $20,005 | $84 |
| Aspiration and/or injection of fluid from large joint | 109 | $15,066 | $67 |
| New patient visit (45+ min) | 71 | $10,697 | $151 |
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 19 | $7,140 | None |
See all 8 services
| Return visit (30+ min) | 142 | $24,072 | $119 |
| Short return visit (20+ min) | 151 | $20,005 | $84 |
| Aspiration and/or injection of fluid from large joint | 109 | $15,066 | $67 |
| New patient visit (45+ min) | 71 | $10,697 | $151 |
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 19 | $7,140 | None |
| New patient visit (30+ min) | 33 | $3,165 | $96 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 104 | $637 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 105 | $65 | None |
Procedures Medicare counted
| Knee replacement | 1-10 | None |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 11 | More than 81% of doctors who do this |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 34 | More than 77% of doctors who do this |
Who their Medicare patients are
276 Original Medicare patients in 2024. Average age 73 · Under 65 4% · 85 and older 5% · Women 52% · Health risk score 0.79. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 49% · Coronary heart disease 20% · Depression 15% · Cancer 14% · Atrial fibrillation 13% · Chronic kidney disease 11% · Diabetes 10% · Heart failure 6% · COPD 5%.
The office billed $498,787, Medicare allowed $152,002 and paid $118,490; for 19,107 services of 35 kinds; $7,841 of it was for drugs given in the office and $110,649 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 276 | 19,107 | 73 | 0.79 | $498,787 | $118,490 |
| 2023 | 213 | 9,917 | 74 | 0.79 | $377,782 | $94,956 |
| 2022 | 237 | 11,052 | 73 | 0.78 | $361,573 | $104,492 |
| 2021 | 224 | 8,420 | 73 | 0.73 | $309,721 | $113,496 |
| 2020 | 194 | 5,671 | 72 | 0.73 | $237,743 | $81,724 |
| 2019 | 203 | 1,210 | 72 | 0.83 | $201,054 | $82,383 |
| 2018 | 214 | 1,111 | 71 | 0.89 | $224,932 | $80,846 |
| 2017 | 231 | 1,482 | 71 | 0.83 | $344,068 | $89,363 |
| 2016 | 235 | 2,199 | 71 | 0.69 | $339,234 | $82,602 |
| 2015 | 235 | 2,878 | 70 | 0.70 | $444,109 | $109,820 |
| 2014 | 189 | 4,167 | 69 | 0.68 | $395,557 | $102,379 |
| 2013 | 188 | 3,575 | 69 | 0.69 | $369,215 | $97,351 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 101 | $17,343 | $115 |
| Short return visit (20+ min) | 99 | $13,504 | $81 |
| Aspiration and/or injection of fluid from large joint | 99 | $12,302 | $64 |
| New patient visit (45+ min) | 33 | $5,055 | $153 |
| New patient visit (30+ min) | 48 | $4,515 | $94 |
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 12 | $3,753 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 102 | $589 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 101 | $66 | None |
2022: 9 services
| Return visit (30+ min) | 112 | $19,700 | $118 |
| Short return visit (20+ min) | 131 | $16,173 | $85 |
| Aspiration and/or injection of fluid from large joint | 107 | $14,562 | $68 |
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 14 | $12,103 | None |
| New patient visit (45+ min) | 51 | $7,924 | $155 |
| New patient visit (30+ min) | 33 | $3,382 | $102 |
| Aspiration and/or injection of fluid from medium joint | 15 | $1,163 | $51 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 113 | $730 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 112 | $77 | None |
2021: 8 services
| Return visit (30+ min) | 136 | $28,234 | $114 |
| Aspiration and/or injection of fluid from large joint | 109 | $12,722 | $61 |
| Short return visit (20+ min) | 78 | $10,527 | $80 |
| New patient visit (45+ min) | 57 | $8,723 | $153 |
| New patient visit (30+ min) | 22 | $1,967 | $89 |
| Aspiration and/or injection of fluid from medium joint | 21 | $1,185 | $46 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 118 | $939 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 119 | $114 | None |
2020: 8 services
| Return visit (30+ min) | 114 | $17,108 | $95 |
| Aspiration and/or injection of fluid from large joint | 87 | $8,817 | $57 |
| New patient visit (45+ min) | 38 | $5,225 | $138 |
| Short return visit (20+ min) | 58 | $4,029 | $54 |
| New patient visit (30+ min) | 35 | $2,420 | $69 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 87 | $667 | None |
| Aspiration and/or injection of fluid from medium joint | 11 | $578 | $41 |
| Injection, dexamethasone sodium phosphate, 1 mg | 87 | $57 | None |
2019: 6 services
| Short return visit (20+ min) | 156 | $20,233 | $65 |
| Aspiration and/or injection of fluid from large joint | 86 | $7,999 | $56 |
| New patient visit (30+ min) | 80 | $7,672 | $96 |
| Return visit (30+ min) | 25 | $2,952 | $102 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 88 | $430 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 88 | $17 | None |
2018: 6 services
| Short return visit (20+ min) | 160 | $22,213 | $64 |
| Aspiration and/or injection of fluid from large joint | 102 | $9,467 | $53 |
| New patient visit (30+ min) | 81 | $6,553 | $81 |
| Return visit (30+ min) | 12 | $1,044 | $87 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 101 | $221 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 101 | $15 | None |
2017: 10 services
| Short return visit (20+ min) | 157 | $18,958 | $57 |
| Aspiration and/or injection of fluid from large joint | 98 | $8,974 | $50 |
| New patient visit (30+ min) | 55 | $4,598 | $84 |
| Short return visit | 60 | $3,040 | $39 |
| Long return visit (40+ min) | 15 | $2,093 | $105 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 14 | $1,938 | $138 |
| New patient visit (15+ min) | 21 | $1,381 | $66 |
| Return visit (30+ min) | 12 | $1,168 | $97 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 85 | $483 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 84 | $12 | None |
2016: 6 services
| Short return visit (20+ min) | 201 | $26,424 | $58 |
| Aspiration and/or injection of fluid from large joint | 113 | $9,989 | $46 |
| New patient visit (30+ min) | 67 | $5,472 | $82 |
| Long return visit (40+ min) | 12 | $1,668 | $128 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 103 | $882 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 103 | $17 | None |
2015: 6 services
| Short return visit (20+ min) | 208 | $33,807 | $61 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 19 | $11,188 | None |
| Aspiration and/or injection of fluid from large joint | 109 | $10,281 | $50 |
| New patient visit (30+ min) | 79 | $6,849 | $87 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 101 | $811 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 101 | $21 | None |
2014: 7 services
| Short return visit (20+ min) | 145 | $20,974 | $65 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 26 | $20,513 | None |
| Aspiration and/or injection of fluid from large joint | 96 | $11,849 | $47 |
| Return visit (30+ min) | 74 | $8,632 | $84 |
| New patient visit (30+ min) | 57 | $4,922 | $86 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 88 | $879 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 88 | $64 | None |
2013: 7 services
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 21 | $17,024 | None |
| Return visit (30+ min) | 99 | $15,905 | $91 |
| Short return visit (20+ min) | 122 | $13,961 | $62 |
| Aspiration and/or injection of fluid from large joint | 88 | $9,433 | $47 |
| New patient visit (30+ min) | 65 | $5,778 | $89 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 77 | $737 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 75 | $45 | None |
Drugs they prescribed that Part D paid
$3,155
Pharmacies billed $3,155 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 31% of their Part D prescriptions (89 of 288) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%. Long-acting opioids: 14% of their opioid prescriptions.
285 generic and fewer than 11 brand-name prescriptions · $3,155 in drug cost · 55 antibiotic prescriptions to 46 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycodone-Acetaminophen | 34 | $504 | $15 |
| Promethazine | 42 | $248 | $6 |
| Cephalexin | 41 | $233 | $6 |
| Hydrocodone-Acetaminophen | 17 | $232 | $14 |
| Oxycodone | 23 | $179 | $8 |
See all 7 drugs
| Oxycodone-Acetaminophen | 34 | $504 | $15 |
| Promethazine | 42 | $248 | $6 |
| Cephalexin | 41 | $233 | $6 |
| Hydrocodone-Acetaminophen | 17 | $232 | $14 |
| Oxycodone | 23 | $179 | $8 |
| Ibuprofen | 49 | $174 | $4 |
| Prednisone | 23 | $74 | $3 |
Year by year
| 2024 | 288 | 78 | 31% (89) | None | $3,155 |
| 2023 | 261 | 81 | 31% (80) | None | $6,013 |
| 2022 | 214 | 60 | 36% (78) | None | $11,193 |
| 2021 | 286 | 72 | 36% (104) | 6% | $11,087 |
| 2020 | 231 | 58 | 45% (104) | 5% | $11,801 |
| 2019 | 171 | 71 | 30% (52) | None | $6,031 |
| 2018 | 247 | 91 | 34% (83) | None | $7,075 |
| 2017 | 386 | 97 | 30% (116) | 4% | $11,059 |
| 2016 | 344 | 94 | 32% (111) | 6% | $15,226 |
| 2015 | 396 | 107 | 38% (149) | 11% | $20,716 |
| 2014 | 317 | 88 | 45% (143) | 15% | $26,504 |
| 2013 | 262 | 72 | 34% (89) | 11% | $12,379 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Cephalexin | 35 | $296 | $8 |
| Oxycodone-Acetaminophen | 27 | $245 | $9 |
| Ibuprofen | 40 | $197 | $5 |
| Diclofenac | 14 | $123 | $9 |
| Promethazine | 20 | $121 | $6 |
| Prednisone | 27 | $90 | $3 |
| Hydrocodone-Acetaminophen | 12 | $90 | $7 |
| Oxycodone | 17 | $83 | $5 |
2022: 6 drugs
| Oxycodone | 38 | $265 | $7 |
| Ibuprofen | 35 | $231 | $7 |
| Cephalexin | 30 | $220 | $7 |
| Oxycodone-Acetaminophen | 21 | $201 | $10 |
| Promethazine | 17 | $74 | $4 |
| Prednisone | 20 | $61 | $3 |
2021: 9 drugs
| Enoxaparin | 19 | $2,357 | $124 |
| Ibuprofen | 56 | $485 | $9 |
| Oxycodone-Acetaminophen | 24 | $329 | $14 |
| Oxycodone | 33 | $284 | $9 |
| Cephalexin | 37 | $250 | $7 |
| Morphine Sulfate Er | 16 | $152 | $9 |
| Promethazine | 24 | $134 | $6 |
| Hydrocodone-Acetaminophen | 16 | $132 | $8 |
| Prednisone | 12 | $77 | $6 |
2020: 7 drugs
| Oxycodone-Acetaminophen | 41 | $529 | $13 |
| Oxycodone | 21 | $230 | $11 |
| Ibuprofen | 26 | $178 | $7 |
| Cephalexin | 24 | $106 | $4 |
| Promethazine | 18 | $99 | $6 |
| Hydrocodone-Acetaminophen | 14 | $70 | $5 |
| Prednisone | 12 | $32 | $3 |
2019: 5 drugs
| Oxycodone-Acetaminophen | 19 | $503 | $26 |
| Cephalexin | 24 | $174 | $7 |
| Ibuprofen | 15 | $127 | $8 |
| Promethazine | 11 | $68 | $6 |
| Prednisone | 16 | $58 | $4 |
2018: 10 drugs
| Celecoxib | 19 | $2,586 | $136 |
| Oxycodone-Acetaminophen | 34 | $813 | $24 |
| Diclofenac | 11 | $681 | $62 |
| Hydrocodone-Acetaminophen | 22 | $556 | $25 |
| Oxycodone | 17 | $296 | $17 |
| Ibuprofen | 23 | $158 | $7 |
| Cephalexin | 18 | $125 | $7 |
| Prednisone | 29 | $113 | $4 |
| Promethazine | 15 | $91 | $6 |
| Ibu | 12 | $79 | $7 |
2017: 13 drugs
| Celecoxib | 31 | $4,010 | $129 |
| Enoxaparin | 15 | $1,955 | $130 |
| Oxycodone-Acetaminophen | 53 | $1,701 | $32 |
| Voltaren | 12 | $733 | $61 |
| Ibuprofen | 48 | $424 | $9 |
| Hydrocodone-Acetaminophen | 27 | $304 | $11 |
| Oxycodone | 13 | $182 | $14 |
| Cephalexin | 32 | $175 | $5 |
| Ibu | 16 | $133 | $8 |
| Promethazine | 20 | $127 | $6 |
| Prednisone | 25 | $84 | $3 |
| Amoxicillin | 11 | $23 | $2 |
| Zolpidem | 12 | $16 | $1 |
2016: 11 drugs
| Enoxaparin | 19 | $3,901 | $205 |
| Celecoxib | 29 | $3,236 | $112 |
| Oxycodone-Acetaminophen | 64 | $2,112 | $33 |
| Voltaren | 11 | $643 | $58 |
| Ibuprofen | 49 | $475 | $10 |
| Hydrocodone-Acetaminophen | 14 | $393 | $28 |
| Hydromorphone | 14 | $343 | $24 |
| Cephalexin | 23 | $169 | $7 |
| Promethazine | 15 | $135 | $9 |
| Prednisone | 27 | $127 | $5 |
| Zolpidem | 15 | $98 | $7 |
2015: 12 drugs
| Celecoxib | 31 | $5,202 | $168 |
| Oxycodone-Acetaminophen | 53 | $2,042 | $39 |
| Hydrocodone-Acetaminophen | 48 | $1,029 | $21 |
| Ibuprofen | 54 | $467 | $9 |
| Oxycodone | 11 | $166 | $15 |
| Cephalexin | 26 | $149 | $6 |
| Hydromorphone | 11 | $102 | $9 |
| Zolpidem | 14 | $71 | $5 |
| Prednisone | 15 | $65 | $4 |
| Tramadol | 13 | $63 | $5 |
| Meloxicam | 12 | $53 | $4 |
| Amoxicillin | 11 | $17 | $2 |
2014: 7 drugs
| Celebrex | 31 | $12,606 | $407 |
| Oxycodone-Acetaminophen | 43 | $2,071 | $48 |
| Hydrocodone-Acetaminophen | 49 | $1,067 | $22 |
| Oxycodone | 20 | $655 | $33 |
| Ibuprofen | 37 | $296 | $8 |
| Cephalexin | 13 | $89 | $7 |
| Prednisone | 15 | $64 | $4 |
2013: 7 drugs
| Celebrex | 20 | $6,632 | $332 |
| Oxycodone Hcl-Acetaminophen | 28 | $877 | $31 |
| Hydrocodone-Acetaminophen | 29 | $445 | $15 |
| Ibuprofen | 47 | $259 | $6 |
| Oxycodone | 12 | $225 | $19 |
| Cephalexin | 18 | $147 | $8 |
| Prednisone | 12 | $42 | $3 |
Money from drug and device companies
$414 in 2025
| 2025 | 2 | 4 | None | $414 |
| 2024 | 2 | 2 | None | $76 |
| 2023 | 2 | 2 | None | $71 |
| 2022 | 2 | 16 | $4,000 | $5,156 |
| 2021 | 2 | 3 | $5,500 | $5,625 |
| 2020 | 2 | 2 | None | $41 |
| 2019 | 5 | 41 | $8,100 | $13,266 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vericel | Maci | $367 | 2 payments
|
| Evolution Surgical | None | $48 | 2 payments
|
See all 4 published payments
| Vericel | Meals · 2025-04-30 | Maci | $151 |
| Vericel | Meals · 2025-04-12 | Maci | $215 |
| Evolution Surgical | Meals · 2025-03-19 | None | $22 |
| Evolution Surgical | Meals · 2025-01-04 | None | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $76
| Evolution Surgical | None | $45 | 1 payment
|
| Merck Sharp & Dohme | Bridion | $31 | 1 payment
|
2023: $71
| Evolution Surgical | None | $37 | 1 payment
|
| Merck Sharp & Dohme | Bridion | $34 | 1 payment
|
2022: $5,156
| Arthrex | None | $5,136 | 15 payments
|
| Kowa Pharmaceuticals America | Seglentis | $20 | 1 payment
|
2021: $5,625
| Vericel | Maci | $5,500 | 2 payments
|
| NuVasive | Xlif | $125 | 1 payment
|
2020: $41
| Horizon Therapeutics plc | Pennsaid | $21 | 1 payment
|
| Bioventus | Exogen | $20 | 1 payment
|
2019: $13,266
| Arthrex | None | $6,417 | 26 payments
|
| Vericel | Maci | $5,044 | 8 payments
|
| Smith+Nephew | Latarjet System | $1,645 | 4 payments
|
| Evolution Surgical | None | $109 | 1 payment
|
| Avanos Medical | On-Q* Pump and Accessories | $51 | 2 payments
|
Professional record
- NPI
- 1073569703
- Licence
- CA G82335California G82335: Current · expires 2028-06-30
- Trained
- George Washington University School of Medicine, 1993
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G823350
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- Po Box 31396, Walnut Creek, CA, 94598
- NPI first listed
- 2006-05-25
- NPI last updated
- 2025-11-07
- NPI record certified
- 2025-11-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1375 Sutter Street, San Francisco, CA, 94109 · 2115 the Alameda, San Jose, CA, 95126